US Defense Lab Selects Third Wave Reagents for CF Screening | GenomeWeb

NEW YORK, Dec 9 (GenomeWeb News) - The US Armed Forces Institute of Pathology (AFIP) - the central reference laboratory for the Army, Navy, Air Force, Public Health Service, and Department of Veterans Affairs - has selected Third Wave Technologies' Invader analyte-specific reagents for cystic fibrosis (CF) genetic screening, the company said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.